Medixen Pharma Private Limited - Company Profile

It is a business services private limited company based in Delhi, Delhi, India, established in 2024.
2024 Delhi, Delhi, India Active
Last Updated:
Access Report
About Medixen Pharma Private Limited

Medixen Pharma Private Limited, a active private limited company, was established on 24 August 2024 in Delhi, Delhi, India. it holds CIN: U46497DL2024PTC435829. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Prabha Singh (Director), Uday Shankar Singh (Managing Director). It holds ₹0.50 M open charges and no settled loans. Its latest AGM occurred on 30 December 2025, with the balance sheet filed on 31 March 2025. It is based at Yc Co-Working Space 3Rd F, Plot.94 Dwarka Sector.13, Delhi, Delhi, 110075.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497DL2024PTC435829

  • Registration Number

    435829

  • Incorporation Date

    24 August 2024

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 0.50 M
Company report

Medixen Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Medixen Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Medixen Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Prabha Singh Director 24 Aug 2024 Current
Uday Shankar Singh Managing Director 24 Aug 2024 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medixen Pharma.

Enhance accessibility to Medixen Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Medixen Pharma revenue growth over time
Medixen Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medixen Pharma?

Unlock access to Medixen Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.05 Cr
Latest Charge Details
Date Lender Amount Status
16 Dec 2025 Others ₹0.50 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Medixen Pharma?

Unlock and access historical data on people associated with Medixen Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medixen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medixen Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medixen Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Medixen Pharma Private Limited last Annual general meeting of members was held on 30 Dec 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 0.50 M with Charge ID 101206969 was registered on 16 Dec 2025. was documented.

  • Balance Sheet

    The activity Medixen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.

  • Director Appointment

    Progress on Prabha Singh was appointed as a Director was appointed as a Director on 24 Aug 2024 & has been associated with this company since 1 year 6 months . was documented.

  • Director Appointment

    Progress on Uday Shankar Singh was appointed as a Managing Director was appointed as a Managing Director on 24 Aug 2024 & has been associated with this company since 1 year 6 months . was documented.

  • Company Incorporation

    The activity Medixen Pharma Private Limited was registered on 24 Aug 2024 with Roc Delhi & aged 1 year 6 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Medixen Pharma Private Limited?

The CIN of Medixen Pharma Private Limited is U46497DL2024PTC435829.

Where is Medixen Pharma Private Limited headquartered?

Medixen Pharma Private Limited is headquartered at Yc Co-Working Space 3Rd F, Plot.94 Dwarka Sector.13, Delhi, Delhi, 110075.

When was Medixen Pharma Private Limited incorporated?

Medixen Pharma Private Limited was incorporated on 24 August 2024.

Who are the current directors of Medixen Pharma Private Limited?

The current directors of Medixen Pharma Private Limited are

Is Medixen Pharma Private Limited a listed company?

Medixen Pharma Private Limited is unlisted.

What is the capital structure of Medixen Pharma Private Limited?

The authorized capital of Medixen Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available